Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
Br J Nutr
; 111(7): 1263-71, 2014 Apr 14.
Article
in En
| MEDLINE
| ID: mdl-24299662
Full text:
1
Database:
MEDLINE
Main subject:
Catechin
/
Anti-Obesity Agents
/
Dietary Supplements
/
Metabolic Syndrome
/
Liver
/
Antioxidants
/
Obesity
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Br J Nutr
Year:
2014
Type:
Article
Affiliation country:
Spain